at CNBC.com (Jan 28, 2014)
Oramed Pharmaceuticals (ORMP +1%) gains after receiving approval for a key patent by the Japanese Patent Office. The patent, which has also been approved in Israel and Australia, is titled "Methods and Compositions for Oral Administrations of Proteins," and covers a core concept of the company's technology. ORMP's portfolio now consists of seven issued patents with 28 patents pending.
From other sites
at CNBC.com (Dec 26, 2013)
at MarketWatch.com (Dec 26, 2013)